RN7SL233P

Across TCGA pan-cancer cohorts, RN7SL233P RNA differs between tumor and matched normal tissue in 5 of 18 cancer types tested, making tumor–normal expression one of RN7SL233P’s most consistent transcriptional readouts.

The strongest signal is observed in stomach adenocarcinoma (STAD), where RN7SL233P RNA is more highly expressed in tumor relative to normal tissue. In most cancer types RN7SL233P is over-expressed in tumor, although a few such as KIRC and COAD show the opposite, repressed pattern.

STAD, CHOL, and KIRC are the cancer types where RN7SL233P tumor–normal differential expression is most reproducible.

RNA tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in RN7SL233P RNA (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
STAD	All	All	+0.606	.006	3	view →
CHOL	All	All	+0.418	.003	2	view →
KIRC	Female	IV	−0.306	.031	1	view →
HNSC	All	All	+0.103	.041	1	view →
COAD	All	II,III,IV	−0.098	.038	1	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 5 strongest of 5 lineages.

RN7SL233P–STAD

Open the STAD breakdown →